NK

Nicholas Paul Kwiatkowski

DI Dana-Farber Cancer Institute: 25 patents #19 of 1,343Top 2%
Harvard University: 4 patents #525 of 3,600Top 15%
📍 Brookline, MA: #144 of 3,196 inventorsTop 5%
🗺 Massachusetts: #4,122 of 88,656 inventorsTop 5%
Overall (All Time): #158,612 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
12281126 Inhibitors of cyclin-dependent kinase 7 and uses thereof Nathanael S. Gray, Tinghu Zhang, Jie Jiang, Mingfeng Hao, Zhixiang He 2025-04-22
12168663 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Yanke Liang, Tinghu Zhang 2024-12-17
12098154 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Tinghu Zhang 2024-09-24
11932625 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Nathanael S. Gray, Tinghu Zhang, Baishan Jiang 2024-03-19
11827636 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Yanke Liang 2023-11-28
11325910 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Tinghu Zhang 2022-05-10
11306070 Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Nathanael S. Gray, Tinghu Zhang, Baishan Jiang 2022-04-19
11247991 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Yanke Liang 2022-02-15
11142507 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Tinghu Zhang, Mingfeng Hao 2021-10-12
10870651 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Yanke Liang, Tinghu Zhang 2020-12-22
10865204 Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Yanke Liang, Baishan Jiang +1 more 2020-12-15
10865205 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Yanke Liang 2020-12-15
10787436 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang 2020-09-29
10570154 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Nathanael S. Gray, Xianming Deng 2020-02-25
10550121 Inhibitors of cyclin-dependent kinases Nathanael S. Gray, Tinghu Zhang 2020-02-04
10532103 Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Yanke Liang 2020-01-14
10172905 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Teru Hideshima, Ralph Mazitschek +3 more 2019-01-08
10112927 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang 2018-10-30
10081639 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Nathanael S. Gray, Xianming Deng 2018-09-25
9701683 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Nathanael S. Gray, Xianming Deng 2017-07-11
9572854 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Teru Hideshima, Ralph Mazitschek +3 more 2017-02-21
9464091 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Nathanael S. Gray, Xianming Deng 2016-10-11
9266890 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Nathanael S. Gray, Xianming Deng 2016-02-23
8999289 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Teru Hideshima, Ralph Mazitschek +3 more 2015-04-07
8304451 Histone deacetylase and tubulin deacetylase inhibitors Ralph Mazitschek, James E. Bradner 2012-11-06